Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase.


Journal

Redox biology
ISSN: 2213-2317
Titre abrégé: Redox Biol
Pays: Netherlands
ID NLM: 101605639

Informations de publication

Date de publication:
02 2019
Historique:
received: 09 11 2018
revised: 29 11 2018
accepted: 06 12 2018
pubmed: 24 12 2018
medline: 4 4 2019
entrez: 22 12 2018
Statut: ppublish

Résumé

Obesity and related pathologies such as diabetes and metabolic syndrome are associated with chronic inflammation and cancer. The serum level of xanthine oxidoreductase (XOR) is correlated to obesity-associated metabolic disorders. XOR can play a role in the pathogenesis of both metabolic syndrome and cancer through the inflammatory response and the oxidative stress elicited by the products of its activity. The reactive oxygen and nitrogen species and the uric acid derived from XOR concur to the development of hypertension, dyslipidemia and insulin resistance and participate in both cell transformation and proliferation, as well as in the progression and metastasis process. Despite the availability of different drugs to inhibit in vivo XOR activity, the complexity of XOR inhibition effects should be carefully considered before clinical application, save in the case of symptomatic hyperuricemia.

Identifiants

pubmed: 30576922
pii: S2213-2317(18)31052-8
doi: 10.1016/j.redox.2018.101070
pmc: PMC6302121
pii:
doi:

Substances chimiques

Xanthine Dehydrogenase EC 1.17.1.4

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101070

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Références

Redox Biol. 2015 Dec;6:524-551
pubmed: 26484802
Obes Rev. 2015 Jan;16(1):1-12
pubmed: 25407540
Front Oncol. 2014 Jun 26;4:164
pubmed: 25019059
Child Obes. 2016 Aug;12(4):286-91
pubmed: 26978590
FEBS Lett. 1975 Nov 15;59(2):245-9
pubmed: 179860
Atherosclerosis. 2014 Dec;237(2):562-7
pubmed: 25463089
Annu Rev Med. 2005;56:45-62
pubmed: 15660501
Contrib Nephrol. 2018;192:88-102
pubmed: 29393133
Med Hypotheses. 2018 Sep;118:1-5
pubmed: 30037593
Free Radic Res. 2013 Nov;47(11):958-86
pubmed: 23926919
Biochim Biophys Acta. 2014 Sep;1842(9):1502-17
pubmed: 24882753
Biochem Biophys Res Commun. 2016 Mar 25;472(1):26-32
pubmed: 26903297
Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2107-15
pubmed: 16798827
Cytokine. 2013 Dec;64(3):626-37
pubmed: 24120848
J Diabetes Res. 2016;2016:4370490
pubmed: 27965983
Endocrine. 2014 May;46(1):39-42
pubmed: 24408049
Curr Med Chem. 2016;23(35):4027-4036
pubmed: 27458036
J Reprod Immunol. 2016 Aug;116:98-103
pubmed: 27295433
FEBS J. 2015 Aug;282(16):3075-90
pubmed: 25817260
Arch Toxicol. 2016 Apr;90(4):753-80
pubmed: 26920149
Clin Cancer Res. 2005 Jun 15;11(12):4372-81
pubmed: 15958620
Pharmacol Rep. 2015 Aug;67(4):669-74
pubmed: 26321266
Semin Nephrol. 2011 Sep;31(5):433-40
pubmed: 22000650
Diabetologia. 2015 Sep;58(9):1993-2002
pubmed: 26049401
Diabetes Care. 2012 Nov;35(11):2402-11
pubmed: 23093685
Cardiovasc Ther. 2012 Aug;30(4):217-26
pubmed: 22099531
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Clin Transl Med. 2012 Aug 15;1(1):16
pubmed: 23369448
Diabetes Res Clin Pract. 2018 Sep;143:389-397
pubmed: 29807099
Cancer Res. 1976 Dec;36(12):4639-46
pubmed: 187329
Cancer Med. 2016 Mar;5(3):546-57
pubmed: 26687331
Transl Res. 2015 May;165(5):621-30
pubmed: 25528722
Lancet. 2002 Jul 20;360(9328):187-95
pubmed: 12133652
J Investig Med. 2015 Dec;63(8):924-9
pubmed: 26571421
FEBS J. 2018 Sep;285(18):3337-3352
pubmed: 29775996
Biochim Biophys Acta Mol Basis Dis. 2018 Aug;1864(8):2557-2565
pubmed: 29733945
Metabolism. 2017 May;70:51-56
pubmed: 28403945
Curr Oncol Rep. 2018 Apr 11;20(6):47
pubmed: 29644507
Endocrine. 2012 Jun;41(3):450-7
pubmed: 22350659
Sci Rep. 2014 Apr 01;4:4554
pubmed: 24686534
Proc Nutr Soc. 2012 Feb;71(1):181-9
pubmed: 22051112
Metabolism. 2015 Feb;64(2):182-9
pubmed: 25456095
Oncogenesis. 2017 Sep 25;6(9):e382
pubmed: 28945217
Child Obes. 2014 Apr;10(2):175-80
pubmed: 24568669
PLoS One. 2017 Aug 10;12(8):e0182699
pubmed: 28797123
Oxid Med Cell Longev. 2016;2016:3527579
pubmed: 26823950
Breastfeed Med. 2015 Apr;10(3):175-82
pubmed: 25785349
J Biol Chem. 2013 Sep 20;288(38):27138-49
pubmed: 23913681
Lancet. 2005 Apr 16-22;365(9468):1415-28
pubmed: 15836891
Mediators Inflamm. 2013;2013:136584
pubmed: 23843680
BMC Cardiovasc Disord. 2013 Dec 11;13:115
pubmed: 24330812
Diabetes. 2011 Apr;60(4):1258-69
pubmed: 21346177

Auteurs

Maria Giulia Battelli (MG)

Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy. Electronic address: mariagiulia.battelli@unibo.it.

Massimo Bortolotti (M)

Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy. Electronic address: massimo.bortolotti2@unibo.it.

Letizia Polito (L)

Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy. Electronic address: letizia.polito@unibo.it.

Andrea Bolognesi (A)

Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy. Electronic address: andrea.bolognesi@unibo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH